doi: 10.2174/187152706777452236 63 BardJAWalkerMWBranchekTAWeinshankRL
Artificial intelligence, machine learning, deep learning, and cognitive computing: what do these terms mean and how will they impact health care
49 Global Burden of Disease Study 2013 Collaborators (2015)
Although there is a roadmap for establishing PEDs, lack of public interest, resistance to change, high costs, and lack of participatory processes prevail as challenges
Frier Levitt regulatory attorneys experienced in FDA law and pharmacy law are available to assist clients with strategic advisory, regulatory compliance and enforcement defense services in the GLP-1, compounded drug and peptide space as regulations and enforcement in this sector continues to evolve